Li Dong, Jiang Nan, Pan Minjia, Ma Linzi, Huang Yunchong, Xu Xiaoheng, Yang Xinyan, Zhu Yongtong, Shi Hua, Zhao Shan-Chao
Department of Urology, Nanfang Hospital, Southern Medical University, No. 1023-1063 Shatai South Road, Baiyun District, Guangzhou, 510515, Guangdong, China.
Department of Urology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
J Mol Histol. 2024 Dec 5;56(1):31. doi: 10.1007/s10735-024-10298-y.
Among couples, male factors account for approximately 50% of infertility cases, with nonobstructive azoospermia (NOA) representing one of the most clinically common and severe categories of male infertility, affecting approximately 10-15% of patients. Currently, L-carnitine is clinically used to improve spermatogenesis by regulating Sertoli cell function. Multiple clinical trials have described the efficacy of L-carnitine in treating NOA. Notably, Sertoli cells rely on organic carnitine transporter 2 (OCTN2) for carnitine transport. However, it remains unknown whether OCTN2 expression is involved in the pathological process of NOA.
To investigate the expression and function of OCTN2 in Sertoli cells from patients with NOA.
Ten testicular tissue samples were collected, including five from a healthy group and five from a group of patients with NOA. Immunohistochemistry and immunofluorescence were used to detect the expression of OCTN2 in testicular tissue. Additionally, an Octn2-KO TM4 cell line (a mouse testicular Sertoli cell line) was constructed to explore the function of OCTN2 expression in Sertoli cells through transcriptomic sequencing, cell proliferation experiments, metabolomic analysis, and Western blot analysis.
Compared with those of the healthy group, the immunohistochemistry results revealed a significant decrease in OCTN2 expression in the Sertoli cells of the NOA group. Further investigation through cell proliferation experiments revealed a reduction in the proliferative capacity of the Octn2-KO TM4 cell line. Transcriptomic sequencing and metabolomic data analysis revealed a decrease in autophagy in the Octn2-KO TM4 cell line. Western blot analysis subsequently verified the expression levels of autophagy-related proteins.
In the Sertoli cells of NOA patients, decreased OCTN2 protein expression leads to decreased cell proliferation and autophagy abnormalities, which may play a crucial role in the spermatogenic dysfunction observed in NOA patients.
在不孕夫妇中,男性因素约占不孕病例的50%,其中非梗阻性无精子症(NOA)是男性不育临床上最常见且最严重的类型之一,影响约10%-15%的患者。目前,左旋肉碱在临床上用于通过调节支持细胞功能来改善精子发生。多项临床试验描述了左旋肉碱治疗NOA的疗效。值得注意的是,支持细胞依靠有机肉碱转运体2(OCTN2)来转运肉碱。然而,OCTN2表达是否参与NOA的病理过程仍不清楚。
研究OCTN2在NOA患者支持细胞中的表达及功能。
收集10份睾丸组织样本,其中5份来自健康组,5份来自NOA患者组。采用免疫组织化学和免疫荧光法检测睾丸组织中OCTN2的表达。此外,构建Octn2基因敲除的TM4细胞系(一种小鼠睾丸支持细胞系),通过转录组测序、细胞增殖实验、代谢组分析和蛋白质印迹分析,探讨OCTN2表达在支持细胞中的功能。
免疫组织化学结果显示,与健康组相比,NOA组支持细胞中OCTN2表达显著降低。通过细胞增殖实验进一步研究发现,Octn2基因敲除的TM4细胞系的增殖能力下降。转录组测序和代谢组数据分析显示,Octn2基因敲除的TM4细胞系中自噬减少。蛋白质印迹分析随后验证了自噬相关蛋白的表达水平。
在NOA患者的支持细胞中,OCTN2蛋白表达降低导致细胞增殖减少和自噬异常,这可能在NOA患者观察到的生精功能障碍中起关键作用。